Table 3.

Nomograms on pre-treatment prediction of biochemical recurrence in men treated with radiotherapy

Study	Prediction model	BCR (years)	Radiation type	No of patients	Variables	Discrimination
Zagars et al71	Probability graph	6	EBRT	938	PSA, biopsy GS, CS	NA
D'Amico et al72	Probability table	2	EBRT	762	Biopsy GS, CS, PSA	NA
Shipley et al73	Probability table	5	EBRT	1607	Biopsy GS, CS, PSA	NA
Kattan et al74	Probability nomogram development	5	EBRT	1042/1030	PSA, biopsy GS, CS, neoadjuvant ADT, radiation dose delivered	73%
D'Amico et al75	Probability graph	5	EBRT	766	Biopsy GS, CS, PSA, treatment modality	NA
Ragde et al76	Risk group	10	BT	98	Age, biopsy GS, CS, PSA, 45 Gy EBRT	76%
Kattan et al12	Probability nomogram development	5	BT	920, 1827, 765	Biopsy GS, CS, PSA, co-administration of EBRT	61–64%

BCR, biochemical recurrence; EBRT, external beam radiotherapy; BT, brachytherapy; GS, Gleason sum; ADT, androgen deprivation therapy; NA, not available.